Ethylenediamine

Ethylenediamine

SCHEMBL29504146

NCCN.NCCN.NCCN.[Co+3]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.44
TSHR P16473 4/20 0.40
CA12 O43570 4/20 0.40
CA6 P23280 4/20 0.40
CA7 P43166 4/20 0.40
CA9 Q16790 4/20 0.40
CA14 Q9ULX7 4/20 0.40
CA5B Q9Y2D0 4/20 0.40
ALDH1A1 P00352 4/20 0.40
LMNA P02545 4/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA3 P07451 3/20 0.40
CA4 P22748 3/20 0.40
CA5A P35218 3/20 0.40
BLM P54132 2/20 0.40
DNM1 Q05193 1/20 0.40
CYP3A4 P08684 1/20 0.40
TDP1 Q9NUW8 4/20 0.36
MAPT P10636 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylenediamine SCHEMBL440459 0.93 NFKB1 (0.40) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL10449623 0.93 NFKB1 (0.40) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL8214834 0.93
Ethylenediamine SCHEMBL28924405 0.91 NFKB1 (0.50) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL37647 0.91
Ethylenediamine SCHEMBL30253568 0.91
Ethylenediamine SCHEMBL3083 0.91
Ethylenediamine SCHEMBL7085968 0.91 NFKB1 (0.50) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL1450484 0.87 NFKB1 (0.36) NFKB1TSHRCA12CA6CA7
Ethylenediamine SCHEMBL23633140 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534489-B2 Ionic solid JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2026-01-27 US claimed
US-20220135607-A1 IONIC SOLID JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2022-05-05 US claimed
US-12534489-B2 Ionic solid JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2026-01-27 US disclosed
EP-4650469-A1 PROCESS FOR ELECTROMEDIATED METAL STRIPPING AND RECOVERY UNIVERSITE CLAUDE BERNARD - LYON 1 (FR) 2025-11-19 EP disclosed
US-20250230555-A1 VANADIUM-DOPED MANGANESE COBALT SPINEL OXIDE BASED ELECTROCATALYSTS FOR GENERATING HYDROGEN KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-07-17 US disclosed
US-12312628-B2 Metabolic control over organometallic catalysts using electroactive bacteria THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-05-27 US disclosed
CN-118595580-A Working face manufacturing method and device based on shock wave coupling field dimension reduction guide control 贵州华科铝材料工程技术研究有限公司 2024-09-06 CN disclosed
US-20240261770-A1 COBALT CATALYSTS CONTAINING \"SMART\" OR \"TASK SPECIFIC\" ANIONS THE TEXAS A&M UNIVERSITY SYSTEM (US) 2024-08-08 US disclosed
US-11860084-B2 Quantitative auxiliary-free chirality sensing with a metal probe GEORGETOWN UNIVERSITY (US) 2024-01-02 US disclosed
WO-2022256525-A1 COBALT CATALYSTS CONTAINING \"SMART\"OR\"TASK SPECIFIC\"ANIONS THE TEXAS A&M UNIVERSITY SYSTEM (US) 2022-12-08 WO disclosed
CN-110165048-B Transition metal oxide resistive switching device with doped buffer 塞姆特里克斯内存有限公司 2022-11-01 CN disclosed
US-20220135607-A1 IONIC SOLID JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2022-05-05 US disclosed
US-20220113247-A1 QUANTITATIVE AUXILIARY-FREE CHIRALITY SENSING WITH A METAL PROBE GEORGETOWN UNIVERSITY 2022-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534489-B2 Ionic solid ADH1C, ADM2, SLC2A1 NFKB1 1535/4885TSHR 2905/4885CA12 95/4885
US-20220135607-A1 IONIC SOLID NUP160, NUP188, NUP210 NFKB1 3262/4885TSHR 4492/4885CA12 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.